Tag: Alliance for Hippocratic Medicine v. FDA
Court Rules to Reinstate Significant Restrictions on Abortion Medication but Not to Revoke FDA Approval of the Drug
Mifepristone will remain available under current regulations due to an earlier U.S. Supreme Court order.
Health, Pharmaceutical and Legal Experts Urge Circuit Court to Reverse Order Attempting to Block FDA’s Approval of Abortion Drug
Case to be argued at the Fifth Circuit Court of Appeals on May 17.
The Center and Movement Partners Urge Court to Block Unprecedented Ruling Rejecting FDA’s Approval of Abortion Drug
Amicus brief of more than 100 reproductive rights, health, and justice partners highlights the proven safety and efficacy of the drug, the ruling’s “immediate and life-threatening consequences,” and the court’s reliance on “debunked data.”
Texas Court’s Radical Decision Attempts to Block FDA Approval of a Medication Abortion Drug Used for More Than 20 Years
Ruling is a devastating blow to abortion access across the U.S.
Texas judge could end access to abortion medication mifepristone nationwide
In an interview with MSNBC, President and CEO Nancy Northup discusses the lawsuit filed against the FDA to remove an abortion medication in all 50 states.
A Texas judge could force a major abortion pill off the market
Senior Counsel Jenny Ma was interviewed for this piece by NPR.
Nationwide Threat to Medication Abortion
Anti-abortion advocates sue the FDA attempting to remove an abortion medication in all 50 states.
